Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

251.15
-7.2000-2.79%
Post-market: 251.150.00000.00%17:28 EDT
Volume:656.36K
Turnover:166.30M
Market Cap:32.75B
PE:-119.69
High:260.00
Open:259.92
Low:250.35
Close:258.35
Loading ...
Aug 03, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Major Issues Report

8-K - Current report
Apr 29, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2021

Major Issues Report

8-K - Current report
Apr 12, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 11, 2021

Major Issues Report

8-K - Current report
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 14, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Oct 02, 2020

Major Issues Report

8-K - Current report
Aug 20, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]